# PARP inhibitors for BRCA1/2-mutated and sporadic ovarian cancer: current practice and future directions

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/parp-inhibitors-for-brca1-2-mutated-and-sporadic-ovarian-cancer-current-practice/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Gottfried E. Konecny,Rebecca Kristeleit |
| Citations | 213 |
| DOI | 10.1038/bjc.2016.311 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/bjc2016311.pdf |
| OpenAlex ID | https://openalex.org/W2531736191 |
| PMID | 27736844 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Rebecca Kristeleit](https://scholariq.org/researchers/rebecca-kristeleit/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.